http://www.acadia-pharm.com
ACADIA Pharmaceuticals Inc. Company Intro
As a leader in developing and commercializing innovative therapies for central nervous system disorders we are committed to improving the lives of patients.
Industry
Healthcare
ACADIA Pharmaceuticals Inc. Headquaters
3611 Valley Centre Drive
San Diego,92130
United States
ACADIA Pharmaceuticals Inc. Share price
17 May 2023 12:42 GMT
$21.79
-0.33 (-1.49 %)
ACADIA Pharmaceuticals Inc. Market cap
$3.588 B
WMC RANKING
2024
ACADIA Pharmaceuticals Inc. # 26
BiotechnologyLatest ACADIA Pharmaceuticals Inc. News
12 Feb 2024
New York State Common Retirement Fund Grows Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
New York State Common Retirement Fund lifted its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 43.8% in the 3rd quarter, according to...
12 Feb 2024
New CEO rises to challenge as Lundbeck eyes competition
Danish drugmaker Lundbeck has its eye on steady growth over the medium term, a strategy which new chief executive Charl van Zyl believes could be key to the...
12 Feb 2024
Autism Spectrum Disorders Treatment Market Size and Global Forecast 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033
WMC Market Score
WMC Market to Revenue Score
ACADIA Pharmaceuticals Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| ACADIA Pharmaceuticals Inc. | USD | $458,241 | $701,816 | $-260,009 | $35,880B | 26 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total ACADIA Pharmaceuticals Inc. Social Followers vs Top 4 Industry Competitors
ACADIA Pharmaceuticals Inc. Post vs Top 4 Industry Competitors
ACADIA Pharmaceuticals Inc. Digital Footprint By Size vs Top 4 Industry Competitors
ACADIA Pharmaceuticals Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
ACADIA Pharmaceuticals Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| ACADIA Pharmaceuticals Inc. | 4.98 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
